Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Topiramate by CURx Pharmaceuticals for Migraine: Likelihood of Approval
Topiramate is under clinical development by CURx Pharmaceuticals and currently in Phase I for Migraine. According to GlobalData, Phase I...
Data Insights
Topiramate by CURx Pharmaceuticals for Epilepsy: Likelihood of Approval
Topiramate is under clinical development by CURx Pharmaceuticals and currently in Phase I for Epilepsy. According to GlobalData, Phase I...